サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1300958

心房細動の市場規模、シェア、動向分析レポート：治療タイプ別、最終用途別、地域別、セグメント予測：2023年～2030年

Atrial Fibrillation Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment), By End-use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 105 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心房細動の市場規模、シェア、動向分析レポート：治療タイプ別、最終用途別、地域別、セグメント予測：2023年～2030年
出版日: 2023年06月02日
発行: Grand View Research
ページ情報: 英文 105 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心房細動市場の成長と動向

GrandView Research, Inc.の最新レポートによると、心房細動の世界市場規模は2030年までに480億1,000万米ドルに達し、CAGR 10.1%で推移すると予測されています。

米国国立衛生研究所によると、心房細動は全世界で3,750万人（人口の0.51％）が罹患しており、過去20年間で33％増加しています。

さらに、世界中で数百万人が心房細動の影響を受けており、毎年数千人が入院し、死亡していることから、革新的な治療法と解決策が切実に求められています。米国だけでも、CDCの報告によると、心房細動を主な診断とする入院は毎年45万4千件近くに上り、15万8千人以上が死亡しています。これらの数字は、心房細動の診断、治療、管理のための新製品を開発し販売する企業にとって、大きな市場機会があることを示しています。

心房細動は一般的に救急部で治療されるが、COVID-19のパンデミックの間、パンデミック前と比較して心房細動の一次診断による入院は減少しています。にもかかわらず、2021年にMDPIが発表した論文では、COVID-19患者の最大7.5％が心房細動を発症する可能性があり、心房細動治療の需要が増加する可能性があるとしています。しかし、他の研究では、患者の行動の変化、心房細動治療の減少、特定の医療機器や装置の不足を引き起こす世界サプライチェーンの混乱などにより、パンデミック時に持続性心房細動や発作性心房細動の患者の受診が減少したことが報告されています。

主要企業による政府承認の増加や新製品の発売は、心房細動製品市場の成長を促進すると予想されます。例えば、2023年3月、メドトロニック社は、Affera Prism-1 Mapping SoftwareとSphere-9カテーテルを用いて心房性不整脈を治療するアブレーションシステムとAffera MappingのCEマーク承認を取得しました。このシステムは、高周波アブレーション、パルスフィールドアブレーション、高密度マッピングカテーテルを統合し、異常な心臓のリズムをリアルタイムでフィードバックし、正確なマッピングとアブレーションを提供するもので、電気生理学の新たな標準となるものです。

心房細動市場レポートハイライト

  • 治療タイプに基づき、心房細動市場は薬理学的治療と非薬理学的治療に区分されます。薬理学的治療分野は、抗凝固薬と抗不整脈薬の需要が高いことから、2022年の心房細動市場で65％以上の最大収益シェアを占めました。
  • 最終用途に基づき、市場はさらに病院、専門クリニック、その他に分類されます。病院セグメントは2022年に市場で最大のシェアを占め、予測期間中に10.4%の最速CAGRを記録すると予測されます。このセグメントの急成長は、主に病院で行われる手術件数の多さに起因しています。
  • 北米地域は心房細動の罹患率の増加と患者数の多さから、市場を独占し、2022年には39％以上の最大の収益シェアを占めると予測されます。
  • アジア太平洋地域は、特に中国やインドなどの新興経済圏で近年医療インフラへの投資が増加しているため、推定・予測期間中に最も速い速度で成長すると予測されます。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 市場の定義
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報と第三者の視点
    • 1次調査
    • 1次調査の詳細
  • 情報分析
    • データ分析モデル
  • 市場の形成とデータの視覚化
    • 商品フロー分析
  • データの検証と公開
  • 世界市場：CAGRの計算
  • 二次情報のリスト
  • 一次情報のリスト

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し
  • 市場動向と展望
  • 市場力学
  • 市場抑制要因分析
  • 事業環境分析
    • SWOT分析;要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 治療タイプのビジネス分析

  • 心房細動市場、治療タイプ別：重要なポイント
  • 心房細動市場：治療タイプの動向と市場シェア分析、2022年および2030年
  • 薬物治療
    • 世界の薬物治療市場推計・予測、2018年から2030年まで
    • 抗不整脈薬
    • 抗凝固薬
  • 非薬物療法
    • 世界の非薬物療法市場推計・予測、2018年から2030年
    • カテーテルアブレーション
    • 迷路手術
    • 電気除細動

第5章 最終用途のビジネス分析

  • 心房細動市場、最終用途別：重要なポイント
  • 心房細動市場：最終用途の動きと市場シェア分析、2022年と2030年
  • 病院
    • 世界の病院市場推計・予測、2018～2030年
  • 専門クリニック
    • 世界の専門クリニック市場推計・予測、2018年から2030年
  • その他
    • 世界のその他市場推計・予測、2018～2030年

第6章 地域のビジネス分析

  • 地域市場のスナップショット
  • 地域別の市場シェア分析、2022年
  • 北米
    • 北米心房細動市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州心房細動市場、2018年～2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋心房細動市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの心房細動市場、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ心房細動市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業プロファイル・リスト
    • AtriCure Inc.
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation.
    • Bristol-Myers Squibb Corporation
    • Cardio Focus Inc.
    • Sanofi Aventis
    • Biosense Webster Inc.
    • Endoscopic Technologies Inc.
    • Abbott（St. Jude Medical Inc.）
    • Johnsons &Johnson
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 3 Global Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Atrial Fibrillation Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 7 North America Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 11 Canada Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 14 Europe Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 16 Germany Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 18 UK Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 20 France Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 22 Italy Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 24 Spain Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 30 Norway Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 China Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 35 China Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 37 Japan Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 39 India Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 43 Australia Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 45 Thailand Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Atrial Fibrillation Market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 48 Latin America Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 50 Brazil Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 52 Mexico Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 58 South Africa Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 UAE Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 62 UAE Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Atrial Fibrillation Market, by treatment type, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Atrial Fibrillation Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Atrial Fibrillation Market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2022
  • Fig. 15 Global Atrial Fibrillation Market: treatment type outlook key takeaways
  • Fig. 16 Global Atrial Fibrillation Market: treatment type movement analysis
  • Fig. 17 Pharmacological Treatment market, 2018 - 2030 (USD Million)
  • Fig. 18 Anti-arrhythmic Drugs market, 2018 - 2030 (USD Million)
  • Fig. 19 Anticoagulant Drugs market, 2018 - 2030 (USD Million)
  • Fig. 20 Non-Pharmacological Treatment market, 2018 - 2030 (USD Million)
  • Fig. 21 Catheter Ablation market, 2018 - 2030 (USD Million)
  • Fig. 22 Radiofrequency market, 2018 - 2030 (USD Million)
  • Fig. 23 HIFU market, 2018 - 2030 (USD Million)
  • Fig. 24 Cryoablation market, 2018 - 2030 (USD Million)
  • Fig. 25 Microwave market, 2018 - 2030 (USD Million)
  • Fig. 26 Laser market, 2018 - 2030 (USD Million)
  • Fig. 27 Maze Surgery market, 2018 - 2030 (USD Million)
  • Fig. 28 Electric Cardioversion market, 2018 - 2030 (USD Million)
  • Fig. 29 Global Atrial Fibrillation Market: end-use outlook key takeaways
  • Fig. 30 Global Atrial Fibrillation Market: end-use movement analysis
  • Fig. 31 Global Hospital market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Specialty Clinics market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 Regional outlook, 2022 & 2030
  • Fig. 36 Global Atrial Fibrillation Market: region movement analysis
  • Fig. 37 North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 60 Middle East and Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-004-0

Atrial Fibrillation Market Growth & Trends

The global atrial fibrillation market size is expected to reach USD 48.01 billion by 2030, registering at a CAGR of 10.1%, according to a new report by Grand View Research, Inc.Aging population, lifestyle changes, and chronic diseases such as diabetes and obesity are factors contributing to the increasing incidence of atrial fibrillation (AFib). The National Institute of Health reports that AFib affects 37.5 million people globally (0.51% of the population), a 33% increase in the past 20 years.

Moreover, with millions worldwide affected by AFib, and thousands of hospitalizations and deaths annually, there is a critical need for innovative therapies and solutions. In the U.S. alone, the CDC reports almost 454,000 hospitalizations with AFib as the primary diagnosis each year, resulting in over 158,000 deaths. These numbers highlight a significant market opportunity for companies to develop and market new products for diagnosing, treating, and managing atrial fibrillation.

Atrial fibrillation is commonly treated in emergency departments, but during the COVID-19 pandemic, there has been a decrease in admissions for primary diagnoses of AF compared to pre-pandemic times. Despite this, the article published by MDPI in 2021 states that up to 7.5% of COVID-19 patients may develop AF, which could increase the demand for AF treatments. However, other studies have reported a decrease in visits by patients with persistent and paroxysmal atrial fibrillation during the pandemic, due to changes in patient behavior, a decline in AF procedures, and disruptions to global supply chains causing shortages of certain medical devices and equipment.

Increasing government approvals and new product launches by key players are expected to drive growth in the atrial fibrillation products market. For instance, in March 2023, Medtronic received CE Mark approval for its Ablation System and Affera Mapping, which is designed to treat atrial arrhythmias using the Affera Prism-1 Mapping Software and Sphere-9 Catheter. This system integrates radiofrequency, pulsed field ablation, and high-density mapping catheter to provide real-time feedback and accurate mapping and ablation of abnormal heart rhythms, creating a new standard in electrophysiology.

Atrial Fibrillation Market Report Highlights

  • Based on treatment type, the AFib market is segmented into pharmacological and non-pharmacological treatment. Pharmacological treatment segment held the largest revenue share of over 65% of the atrial fibrillation market in 2022, due to the high demand for anticoagulant drugs and anti-arrhythmic drugs
  • Based on end-use, the market has been further categorized into hospitals, specialty clinics, and others. The hospitals segment accounted for the largest share of the market in 2022, and it is estimated to register the fastest CAGR of 10.4% during the forecast period. The segment's rapid growth is primarily attributed to the high number of surgeries performed in hospitals
  • The North American region is expected to dominate the market and held the largest revenue share of over 39% in 2022, owing to the increasing incidence of atrial fibrillation and a large patient population
  • Asia Pacific is estimated to grow at the fastest rate during the forecast period due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Treatment Type Business Analysis

  • 4.1. Atrial Fibrillation Market, By Treatment Type: Key Takeaways
  • 4.2. Atrial Fibrillation Market: Treatment Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Pharmacological Treatment
    • 4.3.1. Global Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Anti-arrhythmic Drugs
      • 4.3.2.1. Global Anti-arrhythmic Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Anticoagulant Drugs
      • 4.3.3.1. Global Anticoagulant Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Non-Pharmacological Treatment
    • 4.4.1. Global Non-Pharmacological Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Catheter Ablation
      • 4.4.2.1. Global Catheter Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Radiofrequency
      • 4.4.2.2.1. Global Radiofrequency Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. HIFU
      • 4.4.2.3.1. Global HIFU Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.4. Cryoablation
      • 4.4.2.4.1. Global Cryoablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.5. Microwave
      • 4.4.2.5.1. Global Microwave Market Estimates and Forecasts, 2018 - 2030 (USD Million
      • 4.4.2.6. Laser
      • 4.4.2.6.1. Global Laser Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Maze Surgery
      • 4.4.3.1. Global Maze Surgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Electric Cardioversion
      • 4.4.4.1. Global Electric Cardioversion Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Atrial Fibrillation Market, By End-Use: Key Takeaways
  • 5.2. Atrial Fibrillation Market: End-Use Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Specialty Clinics
    • 5.4.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. Market Share Analysis by Region, 2022
  • 6.3. North America
    • 6.3.1. North America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Canada Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.3. UK
      • 6.4.3.1. UK Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. France Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Italy Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Spain Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Denmark Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Sweden Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Norway Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. China Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. India Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. South Korea Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Australia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Thailand Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. South Africa Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Saudi Arabia Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. UAE Atrial Fibrillation Market, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait Atrial Fibrillation Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. AtriCure Inc.
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Boehringer Ingelheim GmbH
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Boston Scientific Corporation.
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Bristol- Myers Squibb Corporation
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Cardio Focus Inc.
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sanofi Aventis
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Biosense Webster Inc.
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Endoscopic Technologies Inc.
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Abbott (St. Jude Medical Inc.)
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Johnsons & Johnson
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives